#	Pagina
attuale pagina	/open-h2020/projects/197243/index.html

Opendata, web and dolomites

MELGEN SIGNED

MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

MELGEN project word cloud

Explore the words cloud of the MELGEN project. It provides you a very rough idea of what is the project "MELGEN" about.

interoperable therapy melanomas industry melanoma statistics progression tools biomarking applies frameworks eagle precision recommendations communications immunid training immunity genomic 15 biomarkers translational recruit models digital host esrs foundation inter create etn treat genetics immunology made sectorial insufficient drivers medicine clinical collaborative science private cancer potentially underpin tumour ultimate suppress datasets stage decision generation considerable professionals environment personalised applicable provision commercial public education cancers controls progress predictive immunological innovative tests servicexs melgen survival report accessible determinants prognostic immunogenic genetic leaders biotech recommended genomics network drive interdisciplinary bioinformatics 2012 digitronix core

Project "MELGEN" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITY OF LEEDS Organization address address: WOODHOUSE LANE city: LEEDS postcode: LS2 9JT website: www.leeds.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.melgen.org
Total cost	3˙988˙365 €
EC max contribution	3˙988˙365 € (100%)
Programme	1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
Code Call	H2020-MSCA-ITN-2014
Funding Scheme	MSCA-ITN-ETN
Starting year	2015
Duration (year-month-day)	from 2015-06-01 to 2019-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITY OF LEEDS UNIVERSITY OF LEEDS Organization address address: WOODHOUSE LANE city: LEEDS postcode: LS2 9JT website: www.leeds.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LEEDS)	coordinator	819˙863.00
2	LUNDS UNIVERSITET LUNDS UNIVERSITET Organization address address: Paradisgatan 5c city: LUND postcode: 22100 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (LUND)	participant	790˙977.00
3	UNIVERSITAETSKLINIKUM ESSEN UNIVERSITAETSKLINIKUM ESSEN Organization address address: HUFELANDSTRASSE 55 city: ESSEN postcode: 45147 website: www.uk-essen.de/frauenklinik/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (ESSEN)	participant	747˙649.00
4	OSLO UNIVERSITETSSYKEHUS HF OSLO UNIVERSITETSSYKEHUS HF Organization address address: KIRKEVEIEN 166 TARNBYGGET city: OSLO postcode: 450 website: http://www.oslo-universitetssykehus.no contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	participant	572˙550.00
5	GENOME RESEARCH LIMITED GENOME RESEARCH LIMITED Organization address address: THE GIBBS BUILDING, EUSTON ROAD 215 city: LONDON postcode: NW1 2BE website: http://www.sanger.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	546˙575.00
6	ACADEMISCH ZIEKENHUIS LEIDEN ACADEMISCH ZIEKENHUIS LEIDEN Organization address address: ALBINUSDREEF 2 city: LEIDEN postcode: 2333 ZA website: www.lumc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (LEIDEN)	participant	510˙748.00

Map

Project objective

MELGEN (MELanoma GENetics) – understanding and biomarking the genetic and immunological determinants of melanoma survival

The MELGEN European Training Network (ETN) will create an environment for long-term, collaborative, inter-sectorial cancer genetics research with the ultimate aim of improving precision (personalised) medicine. In a 2012 report the European Science Foundation identified the importance of precision medicine and recommended that there should be 1) provision of comprehensive, accessible and interoperable datasets 2) improved models and decision-making processes, 3) interdisciplinary, public-private partnerships and translational research, and 4) dedicated funding including access to core technology and frameworks for education and training of professionals. This application addresses all four recommendations and applies them to melanoma. Considerable, but insufficient, progress has been made in understanding the genetic changes within melanomas that drive tumour progression, and how those drivers can be targeted to treat melanoma. Melanoma is also an especially immunogenic cancer and much more needs to be understood of how melanomas suppress host immunological responses. Understanding what controls immunity in melanoma will be potentially applicable to other cancers. Finally, we need prognostic and predictive biomarkers for selection of precision therapy. This ETN will recruit 15 early stage researchers (ESRs) to address these issues. It will bring together leaders in clinical research, genomics, statistics, bioinformatics, and the biotech industry to exploit the new genomic tools and tumour immunology. MELGEN’s commercial partners are developing immunological tests (ImmunID), bioinformatics (Eagle Genomics), commercial genomics (ServiceXS) and digital design/communications (Digitronix) and they will underpin an innovative, interdisciplinary training programme for the next generation of melanoma researchers.

Deliverables

List of deliverables.
D7.1	Documents, reports	2019-04-30 15:37:08
D6.2	Other	2019-04-30 15:37:08
D6.1	Other	2019-04-30 15:37:08

Take a look to the deliverables list in detail: detailed list of MELGEN deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2020	Shamik Mitra, Martin Lauss, Rita Cabrita, Jiyeon Choi, Tongwu Zhang, Karolin Isaksson, HÃ¥kan Olsson, Christian Ingvar, Ana Carneiro, Johan Staaf, Markus RingnÃ©r, Kari Nielsen, Kevin M. Brown, GÃ¶ran JÃ¶nsson Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma published pages: , ISSN: 1574-7891, DOI: 10.1002/1878-0261.12663	Molecular Oncology	2020-03-13
2017	Rahul Metri, Abhilash Mohan, JÃ©rÃ©mie Nsengimana, Joanna Pozniak, Carmen Molina-Paris, Julia Newton-Bishop, David Bishop, Nagasuma Chandra Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach published pages: 17314, ISSN: 2045-2322, DOI: 10.1038/s41598-017-17330-0	Scientific Reports 7/1	2020-03-05
2018	Sabrina A. Hogan, Mitchell P. Levesque, Phil F. Cheng Melanoma Immunotherapy: Next-Generation Biomarkers published pages: , ISSN: 2234-943X, DOI: 10.3389/fonc.2018.00178	Frontiers in Oncology 8	2020-03-05
2020	Metzenmacher, VÃ¡raljai, HegedÃ¼s, Cima, Forster, Schramm, Scheffler, Horn, Klein, Szarvas, Reis, Bielefeld, Roesch, Aigner, Kunzmann, Wiesweg, Siveke, Schuler, Lueong Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer published pages: 353, ISSN: 2072-6694, DOI: 10.3390/cancers12020353	Cancers 12/2	2020-03-05
2019	Marina Juraleviciute, Joanna Pozniak, JÃ©rÃ©mie Nsengimana, Mark Harland, Juliette Randersonâ€Moor, Patrik Wernhoff, Assia Bassarova, Geir Frode Ã˜y, Gunhild TrÃ¸en, Vivi Ann FlÃ¸renes, David Timothy Bishop, Meenhard Herlyn, Julia Newtonâ€Bishop, Ana Slipicevic MX 2 is a novel regulator of cell cycle in melanoma cells published pages: , ISSN: 1755-1471, DOI: 10.1111/pcmr.12837	Pigment Cell & Melanoma Research	2020-03-05
2019	Rohit Thakur, Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally Jane O\'Shea, Joanna PoÅºniak, Anastasia Filia, Mark Harland, Joanne Gascoyne, Juliette A. Randerson-Moor, May Chan, Tracey Mell, GÃ¶ran JÃ¶nsson, D. Timothy Bishop, Julia Newton-Bishop, Jennifer H. Barrett, JÃ©rÃ©mie Nsengimana Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma published pages: 7424-7435, ISSN: 1078-0432, DOI: 10.1158/1078-0432.ccr-18-3659	Clinical Cancer Research 25/24	2020-03-05
2019	Anastasia Filia, Alastair Droop, Mark Harland, Helene Thygesen, Juliette Randerson-Moor, Helen Snowden, Claire Taylor, Joey Mark S. Diaz, Joanna Pozniak, JÃ©rÃ©mie Nsengimana, Jon Laye, Julia A. Newton-Bishop, D. Timothy Bishop High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-45210-2	Scientific Reports 9/1	2020-03-05
2017	Reinhard Dummer, Egle Ramelyte, Sabrina Schindler, Olaf ThÃ¼rigen, Mitchell P. Levesque, Peter Koelblinger MEK inhibition and immune responses in advanced melanoma published pages: e1335843, ISSN: 2162-402X, DOI: 10.1080/2162402X.2017.1335843	OncoImmunology 6/8	2020-03-05
2019	Sabrina A. Hogan, AnaÃ¯s Courtier, Phil F. Cheng, Nicoletta F. Jaberg-Bentele, Simone M. Goldinger, Manuarii Manuel, SolÃ¨ne Perez, Nadia Plantier, Jean-FranÃ§ois Mouret, Thi Dan Linh Nguyen-Kim, Marieke I.G. Raaijmakers, Pia Kvistborg, Nicolas Pasqual, John B.A.G. Haanen, Reinhard Dummer, Mitchell P. Levesque Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma published pages: 77-85, ISSN: 2326-6066, DOI: 10.1158/2326-6066.CIR-18-0136	Cancer Immunology Research 7/1	2020-03-05
2019	Joanna PoÅºniak, JÃ©rÃ©mie Nsengimana, Jonathan P. Laye, Sally J. Oâ€™Shea, Joey Mark S. Diaz, Alastair P. Droop, Anastasia Filia, Mark Harland, John R. Davies, Tracey Mell, Juliette A. Randerson-Moor, Sathya Muralidhar, Sabrina A. Hogan, Sandra Nicole Freiberger, Mitchell P. Levesque, Graham P. Cook, D. Timothy Bishop, Julia Newton-Bishop Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma published pages: 2684-2696, ISSN: 0008-5472, DOI: 10.1158/0008-5472.can-18-2864	Cancer Research 79/10	2020-03-05
2019	Sathya Muralidhar, Anastasia Filia, JÃ©rÃ©mie Nsengimana, Joanna PoÅºniak, Sally J. O\'Shea, Joey M. Diaz, Mark Harland, Juliette A. Randerson-Moor, JÃ¶rg Reichrath, Jonathan P. Laye, Louise van der Weyden, David J. Adams, D.T. Bishop, Julia Newton-Bishop Vitamin Dâ€“VDR Signaling Inhibits Wnt/Î²-Cateninâ€“Mediated Melanoma Progression and Promotes Antitumor Immunity published pages: 5986-5998, ISSN: 0008-5472, DOI: 10.1158/0008-5472.can-18-3927	Cancer Research 79/23	2020-03-05
2018	JÃ©rÃ©mie Nsengimana, Jon Laye, Anastasia Filia, Sally Oâ€™Shea, Sathya Muralidhar, Joanna PoÅºniak, Alastair Droop, May Chan, Christy Walker, Louise Parkinson, Joanne Gascoyne, Tracey Mell, Minttu Polso, Rosalyn Jewell, Juliette Randerson-Moor, Graham P. Cook, D. Timothy Bishop, Julia Newton-Bishop Î²-Cateninâ€“mediated immune evasion pathway frequently operates in primary cutaneous melanomas published pages: 2048-2063, ISSN: 0021-9738, DOI: 10.1172/JCI95351	Journal of Clinical Investigation 128/5	2020-03-05
2019	Bengt Phung, Maciej CieÅ›la, Adriana Sanna, Nicola Guzzi, Giulia Beneventi, Phuong Cao Thi Ngoc, Martin Lauss, Rita Cabrita, Eugenia Cordero, Ana Bosch, Frida Rosengren, Jari HÃ¤kkinen, Klaus Griewank, Annette Paschen, Katja Harbst, HÃ¥kan Olsson, Christian Ingvar, Ana Carneiro, Hensin Tsao, Dirk Schadendorf, Kristian Pietras, Cristian Bellodi, GÃ¶ran JÃ¶nsson The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma published pages: 3573-3586.e7, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2019.05.069	Cell Reports 27/12	2020-03-05
2019	RenÃ¡ta VÃ¡raljai, Kilian Wistuba-Hamprecht, Teofila Seremet, Joey Mark S. Diaz, JÃ©rÃ©mie Nsengimana, Antje Sucker, Klaus Griewank, Jan-Malte Placke, Peter A. Horn, Nils von Neuhoff, Batool Shannan, Heike ChauvistrÃ©, Felix C. E. Vogel, Susanne Horn, JÃ¼rgen C. Becker, Julia Newton-Bishop, Andreas Stang, Bart Neyns, Benjamin Weide, Dirk Schadendorf, Alexander Roesch Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma published pages: 1-10, ISSN: 2473-4284, DOI: 10.1200/po.18.00229	JCO Precision Oncology 3	2020-03-05
2018	R. Varaljai, N. Neuhoff, A. Sucker, J. Newtonâ€Bishop, D. Schadendorf, A. Roesch 45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Zurich, Switzerland, March 7-10, 2018 published pages: e2-e106, ISSN: 0906-6705, DOI: 10.1111/exd.13486	Experimental Dermatology 27/3	2020-03-05
2019	E. Christodoulou, M. Visser, T. P. Potjer, N. van der Stoep, M. RodrÃguez-Girondo, R. van Doorn, N. Gruis Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers published pages: 439-444, ISSN: 1389-9600, DOI: 10.1007/s10689-019-00137-5	Familial Cancer 18/4	2020-03-05
2018	S Leonardelli, S Horn, A Sucker, D Schadendorf, K Griewank, A Paschen PO-399â€…Tumour CDKN2A loss predisposes to immunotherapy resistance published pages: A386.1-A386, ISSN: , DOI: 10.1136/esmoopen-2018-eacr25.911	Genomic Alterations in Cancer 3 (Suppl 2)	2020-03-05
2019	Catarina Salgado, Eliza Mari Kwesi-Maliepaard, Aart G. Jochemsen, Mijke Visser, Mark Harland, Fred van Leeuwen, Remco van Doorn, Nelleke Gruis A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma published pages: 582-589, ISSN: 0960-8931, DOI: 10.1097/cmr.0000000000000640	Melanoma Research 29/6	2020-03-05
2020	Eirini Christodoulou, Remco van Doorn, Mijke Visser, Amina Teunisse, Mieke Versluis, Pieter van der Velden, Nicholas K Hayward, Aart Jochemsen, Nelleke Gruis NEK11 as a candidate high-penetrance melanoma susceptibility gene published pages: 203-210, ISSN: 0022-2593, DOI: 10.1136/jmedgenet-2019-106134	Journal of Medical Genetics 57/3	2020-03-05
2020	Rita Cabrita, Martin Lauss, Adriana Sanna, Marco Donia, Mathilde Skaarup Larsen, Shamik Mitra, Iva Johansson, Bengt Phung, Katja Harbst, Johan Vallon-Christersson, Alison van Schoiack, Kristina LÃ¶vgren, Sarah Warren, Karin JirstrÃ¶m, HÃ¥kan Olsson, Kristian Pietras, Christian Ingvar, Karolin Isaksson, Dirk Schadendorf, Henrik Schmidt, Lars Bastholt, Ana Carneiro, Jennifer A. Wargo, Inge Marie Sva Tertiary lymphoid structures improve immunotherapy and survival in melanoma published pages: 561-565, ISSN: 0028-0836, DOI: 10.1038/s41586-019-1914-8	Nature 577/7791	2020-03-05
2018	Sofia Y. Chen, Rashid Mamunur, Jon Laye, D. Timothy Bishop, Julia A. Newton-Bishop, David J. Adams Abstract 5372: The mutational landscape of primary cutaneous melanoma published pages: 5372-5372, ISSN: , DOI: 10.1158/1538-7445.am2018-5372	Molecular and Cellular Biology / Genetics 78(13 Suppl)	2020-03-05
2019	Adriana Sanna, Katja Harbst, Iva Johansson, Gustav Christensen, Martin Lauss, Shamik Mitra, Frida Rosengren, Jari HÃ¤kkinen, Johan Vallonâ€Christersson, HÃ¥kan Olsson, Ã…sa Ingvar, Karolin Isaksson, Christian Ingvar, Kari Nielsen, GÃ¶ran JÃ¶nsson Tumor genetic heterogeneity analysis of chronic sunâ€damaged melanoma published pages: , ISSN: 1755-1471, DOI: 10.1111/pcmr.12851	Pigment Cell & Melanoma Research	2020-03-05
2018	Carsten Krieg, Malgorzata Nowicka, Silvia Guglietta, Sabrina Schindler, Felix J Hartmann, Lukas M Weber, Reinhard Dummer, Mark D Robinson, Mitchell P Levesque, Burkhard Becher High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy published pages: 144-153, ISSN: 1078-8956, DOI: 10.1038/nm.4466	Nature Medicine 24/2	2020-03-05
2019	Lazaro Hiram Betancourt, Krzysztof PawÅ‚owski, Jonatan Eriksson, A. Marcell Szasz, Shamik Mitra, Indira Pla, Charlotte Welinder, Henrik Ekedahl, Per Broberg, Roger Appelqvist, Maria Yakovleva, Yutaka Sugihara, Kenichi Miharada, Christian Ingvar, Lotta Lundgren, Bo Baldetorp, HÃ¥kan Olsson, Melinda Rezeli, Elisabet Wieslander, Peter Horvatovich, Johan Malm, GÃ¶ran JÃ¶nsson, GyÃ¶rgy Marko-Varga Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-41625-z	Scientific Reports 9/1	2020-03-05
2017	Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese TÃ¶rngren, Anders Kvist, Markus RingnÃ©r, Inge Marie Svane, GÃ¶ran JÃ¶nsson Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma published pages: 1738, ISSN: 2041-1723, DOI: 10.1038/s41467-017-01460-0	Nature Communications 8/1	2020-03-05
2019	Renata Varaljai, Kilian Wistuba-Hamprecht, Teofila Seremet, Joey Mark Santiago Diaz, Jeremie Nsengimana, Antje Sucker, Klaus Griewank, Peter Horn, Nils von Neuhoff, Batool Shannan, Heike ChauvistrÃ©, Felix Christian Eduard Vogel, Susanne Horn, JÃ¼rgen C. Becker, Julia Newton-Bishop, Andreas Stang, Bart Neyns, Benjamin Weide, Dirk Schadendorf, Alexander Roesch ctDNA as a noninvasive monitoring tool in metastatic melanoma. published pages: 9548-9548, ISSN: 0732-183X, DOI: 10.1200/jco.2019.37.15_suppl.9548	Journal of Clinical Oncology 37/15_suppl	2020-03-05
2018	Multiple abstracts from multiple ESRs: Joanna Pozniak, Sathya Muralidhar, Rohit Thakur, Joey Mark Diaz, Shamik Mitra, Adriana Sanna, Rita Cabrita, Sonia Leonardelli, Ishani Banik SMR Congress 2018 Abstracts published pages: 92-172, ISSN: 1755-1471, DOI: 10.1111/pcmr.12738	Pigment Cell & Melanoma Research 32/1	2020-03-05
2018	R Varaljai, N Von Neuhoff, A Sucker, J Newton-Bishop, D Schadendorf, A Roesch PO-493â€…ctDNA profiles of metastatic melanoma patients under therapy published pages: A423.1-A423, ISSN: , DOI: 10.1136/esmoopen-2018-eacr25.995	Poster Presentation: Translational Research 3 (Suppl 2)	2020-03-05
2018	Joanna Pozniak, Jeremie Nsengimana, Jon Laye, Sally O\'Shea, Sabrina Schindler, Mitch Levesque, Tim Bishop, Julia Newton-Bishop Abstract 5204: MYC expression and smoking as drivers of failure of immune response to melanoma published pages: 5204-5204, ISSN: , DOI: 10.1158/1538-7445.am2018-5204	Tumor Biology 78(13 Suppl)	2020-03-05
2020	Catarina Salgado, Jan Oosting, Bart Janssen, Rajiv Kumar, Nelleke Gruis, Remco Doorn Genomeâ€wide characterization of 5â€hydoxymethylcytosine in melanoma reveals major differences with nevus published pages: , ISSN: 1045-2257, DOI: 10.1002/gcc.22837	Genes, Chromosomes and Cancer	2020-03-05
2018	Sathya Muralidhar, Jeremie Nsengimana, Joanna Pozniak, Sally O\'Shea, Jonathan Laye, David Adams, Louise van der Weyden, Timothy Bishop, Julia Newton-Bishop Abstract 5205: Primary melanoma expression of the vitamin D receptor ( VDR ) is protective for melanoma survival and is associated with increased tumor immune response, decreased Wnt/B-catenin signaling and tumor proliferation published pages: 5205-5205, ISSN: , DOI: 10.1158/1538-7445.am2018-5205	Tumor Biology 78(13 Suppl)	2020-03-05
2016	Egle Ramelyte, Sabrina A. Schindler, Reinhard Dummer The safety of anti PD-1 therapeutics for the treatment of melanoma published pages: 41-53, ISSN: 1474-0338, DOI: 10.1080/14740338.2016.1248402	Expert Opinion on Drug Safety 16/1	2020-03-05
2018	Abstracts from ESRs: Marina Juraleviciute, Sabrina Schindler SMR Congress 2017 abstracts published pages: 125-230, ISSN: 1755-1471, DOI: 10.1111/pcmr.12656	Pigment Cell & Melanoma Research 31/1	2020-03-05
2017	Mykyta Artomov, Alexander J. Stratigos, Ivana Kim, Raj Kumar, Martin Lauss, Bobby Y. Reddy, Benchun Miao, Carla Daniela Robles-Espinoza, Aravind Sankar, Ching-Ni Njauw, Kristen Shannon, Evangelos S. Gragoudas, Anne Marie Lane, Vivek Iyer, Julia A. Newton-Bishop, D. Timothy Bishop, Elizabeth A. Holland, Graham J. Mann, Tarjinder Singh, Jeffrey Barrett, David J. Adams, GÃ¶ran JÃ¶nsson, Mark J. Daly, Hensin Tsao Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing published pages: , ISSN: 0027-8874, DOI: 10.1093/jnci/djx083	JNCI: Journal of the National Cancer Institute 109/12	2019-05-27
2017	Simone L. Scholz, Inga MÃ¶ller, Henning Reis, Daniela SÃ¼ÃŸkind, Johannes A. P. van de Nes, Sonia Leonardelli, Bastian Schilling, Elisabeth Livingstone, Tobias Schimming, Annette Paschen, Antje Sucker, Rajmohan Murali, Klaus-Peter Steuhl, Dirk Schadendorf, Henrike Westekemper, Klaus G. Griewank Frequent GNAQ, GNA11 , and EIF1AX Mutations in Iris Melanoma published pages: 3464, ISSN: 1552-5783, DOI: 10.1167/iovs.17-21838	Investigative Opthalmology & Visual Science 58/9	2019-05-27

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MELGEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MELGEN" are provided by the European Opendata Portal: CORDIS opendata.